These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 24218343)

  • 61. Volumetric assessment of epicardial adipose tissue with cardiovascular magnetic resonance imaging.
    Flüchter S; Haghi D; Dinter D; Heberlein W; Kühl HP; Neff W; Sueselbeck T; Borggrefe M; Papavassiliu T
    Obesity (Silver Spring); 2007 Apr; 15(4):870-8. PubMed ID: 17426322
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Acute and chronic effects of epicardial radiofrequency applications delivered on epicardial coronary arteries.
    Viles-Gonzalez JF; de Castro Miranda R; Scanavacca M; Sosa E; d'Avila A
    Circ Arrhythm Electrophysiol; 2011 Aug; 4(4):526-31. PubMed ID: 21685298
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Epicardial adipose tissue volume and adipocytokine imbalance are strongly linked to human coronary atherosclerosis.
    Shimabukuro M; Hirata Y; Tabata M; Dagvasumberel M; Sato H; Kurobe H; Fukuda D; Soeki T; Kitagawa T; Takanashi S; Sata M
    Arterioscler Thromb Vasc Biol; 2013 May; 33(5):1077-84. PubMed ID: 23471228
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Ectopic fat: the true culprit linking obesity and cardiovascular disease?
    Morelli M; Gaggini M; Daniele G; Marraccini P; Sicari R; Gastaldelli A
    Thromb Haemost; 2013 Oct; 110(4):651-60. PubMed ID: 23884194
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Adiposity-associated atrial fibrillation: molecular determinants, mechanisms, and clinical significance.
    Gawałko M; Saljic A; Li N; Abu-Taha I; Jespersen T; Linz D; Nattel S; Heijman J; Fender A; Dobrev D
    Cardiovasc Res; 2023 May; 119(3):614-630. PubMed ID: 35689487
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The Role of Epicardial Fat in Pericardial Diseases.
    Lazaros G; Antonopoulos A; Antoniades C; Tousoulis D
    Curr Cardiol Rep; 2018 Apr; 20(6):40. PubMed ID: 29675684
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Epicardial fat thickness: relationship with plasma visfatin and plasminogen activator inhibitor-1 levels in visceral obesity.
    Malavazos AE; Ermetici F; Cereda E; Coman C; Locati M; Morricone L; Corsi MM; Ambrosi B
    Nutr Metab Cardiovasc Dis; 2008 Oct; 18(8):523-30. PubMed ID: 18083357
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Myocardial, perivascular, and epicardial fat.
    Iozzo P
    Diabetes Care; 2011 May; 34 Suppl 2(Suppl 2):S371-9. PubMed ID: 21525485
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Epicardial fat and vascular risk: a narrative review.
    Katsiki N; Mikhailidis DP; Wierzbicki AS
    Curr Opin Cardiol; 2013 Jul; 28(4):458-63. PubMed ID: 23591557
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Epicardial Adipose Tissue and Cardiovascular Disease.
    Le Jemtel TH; Samson R; Ayinapudi K; Singh T; Oparil S
    Curr Hypertens Rep; 2019 Apr; 21(5):36. PubMed ID: 30953236
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Human epicardial adipose tissue expresses a pathogenic profile of adipocytokines in patients with cardiovascular disease.
    Baker AR; Silva NF; Quinn DW; Harte AL; Pagano D; Bonser RS; Kumar S; McTernan PG
    Cardiovasc Diabetol; 2006 Jan; 5():1. PubMed ID: 16412224
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Epicardial adipose tissue as a mediator of cardiac arrhythmias.
    Patel KHK; Hwang T; Se Liebers C; Ng FS
    Am J Physiol Heart Circ Physiol; 2022 Feb; 322(2):H129-H144. PubMed ID: 34890279
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Obesity and heart].
    Svačina Š
    Vnitr Lek; 2014 Dec; 60(12):1068-71. PubMed ID: 25692834
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Imaging cardiac fat.
    Davidovich D; Gastaldelli A; Sicari R
    Eur Heart J Cardiovasc Imaging; 2013 Jul; 14(7):625-30. PubMed ID: 23539476
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Profiling of Non-Coding Regulators and Their Targets in Epicardial Fat from Patients with Coronary Artery Disease.
    Flinn B; Adams C; Chowdhury N; Gress T; Santanam N
    Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628106
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Epicardial adipose tissue: A cardiovascular risk marker to evaluate in chronic kidney disease.
    D'Marco L; Cortez M; Salazar M; Lima-Martínez M; Bermúdez V
    Clin Investig Arterioscler; 2020; 32(3):129-134. PubMed ID: 31980198
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The role of epicardial adipose tissue in cardiac biology: classic concepts and emerging roles.
    Antonopoulos AS; Antoniades C
    J Physiol; 2017 Jun; 595(12):3907-3917. PubMed ID: 28191635
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Adipose tissue: friend or foe?
    Hassan M; Latif N; Yacoub M
    Nat Rev Cardiol; 2012 Dec; 9(12):689-702. PubMed ID: 23149834
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Epicardial fat and osteoprotegerin - does a mutual relation exist? Pilot study].
    Sovová M; Sovová E; Zapletalová J; Kaletová M; Stejskal D; Sova M; Konečný M; Procházka V; Vrzalová D; Zarivnijová L
    Vnitr Lek; 2018; 64(4):343-346. PubMed ID: 29791169
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Role of adipose tissue in the pathogenesis of cardiac arrhythmias.
    Samanta R; Pouliopoulos J; Thiagalingam A; Kovoor P
    Heart Rhythm; 2016 Jan; 13(1):311-20. PubMed ID: 26277495
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.